Literature DB >> 18390582

Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?

M A Cimmino, G Zampogna, M Parodi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18390582     DOI： 10.1093/rheumatology/ken098

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.

Authors:  Florent L Besson; Jean-Jacques Parienti; Boris Bienvenu; John O Prior; Sylvie Costo; Gerard Bouvard; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

Review 2.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

Review 3.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

4.  Large-vessel giant cell arteritis: a cohort study.

Authors:  Francesco Muratore; Tanaz A Kermani; Cynthia S Crowson; Abigail B Green; Carlo Salvarani; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-09-05       Impact factor: 7.580

Review 5.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.